Gateway Investment Advisers’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$495K Sell
7,355
-415
-5% -$27.6K ﹤0.01% 589
2026
Q1
$488K Buy
+7,770
New +$541K 0.01% 497
2025
Q3
Sell
-2,941
Closed -$257K 530
2025
Q2
$257K Sell
2,941
-167
-5% -$13.1K ﹤0.01% 441
2025
Q1
$212K Buy
3,108
+380
+14% +$31K ﹤0.01% 491
2024
Q4
$212K Sell
2,728
-6,104
-69% -$452K ﹤0.01% 476
2024
Q3
$592K Buy
8,832
+740
+9% +$60.8K 0.01% 371
2024
Q2
$917K Sell
8,092
-70,011
-90% -$8.85M 0.01% 331
2024
Q1
$10.8M Buy
78,103
+69,839
+845% +$8.78M 0.12% 140
2023
Q4
$1.03M Sell
8,264
-148
-2% -$15.1K 0.01% 321
2023
Q3
$785K Sell
8,412
-57,177
-87% -$6.45M 0.01% 334
2023
Q2
$8.43M Sell
65,589
-33,527
-34% -$4.05M 0.1% 164
2023
Q1
$11.5M Buy
99,116
+17,877
+22% +$2M 0.14% 135
2022
Q4
$9.2M Buy
81,239
+76,807
+1,733% +$8.43M 0.11% 160
2022
Q3
$357K Sell
4,432
-1,089
-20% -$92.2K ﹤0.01% 438
2022
Q2
$411K Buy
5,521
+845
+18% +$77.1K ﹤0.01% 450
2022
Q1
$598K Buy
4,676
+1,184
+34% +$130K 0.01% 413
2021
Q4
$469K Buy
3,492
+572
+20% +$82.2K ﹤0.01% 426
2021
Q3
$399K Sell
2,920
-52
-2% -$6.56K ﹤0.01% 440
2021
Q2
$317K Sell
2,972
-112
-4% -$10.8K ﹤0.01% 475
2021
Q1
$277K Sell
3,084
-656
-18% -$61.6K ﹤0.01% 491
2020
Q4
$346K Sell
3,740
-204
-5% -$18.2K ﹤0.01% 453
2020
Q3
$406K Buy
3,944
+788
+25% +$82.3K ﹤0.01% 420
2020
Q2
$320K Sell
3,156
-40,892
-93% -$3.66M ﹤0.01% 461
2020
Q1
$2.96M Buy
44,048
+28
+0.1% +$1.74K 0.04% 269
2019
Q4
$2.41M Sell
44,020
-45,672
-51% -$2.17M 0.02% 327
2019
Q3
$3.35M Sell
89,692
-8,296
-8% -$322K 0.03% 315
2019
Q2
$3.67M Buy
97,988
+15,164
+18% +$477K 0.03% 306
2019
Q1
$2.47M Sell
82,824
-27,672
-25% -$972K 0.02% 341
2018
Q4
$3.31M Buy
+110,496
New +$3.51M 0.03% 318

Other funds holding DXCM

Gateway Investment Advisers's DXCM Position: Q2 2026 in Review

Gateway Investment Advisers reduced its DexCom (DXCM) stake by 5.3% in Q2 2026, selling an estimated $27.6K and leaving 7,355 shares worth $495K. The position accounts for ﹤0.01% of the portfolio, ranked #589.

Gateway Investment Advisers first reported a position in DXCM in Q4 2018 and has held it in 29 quarters since. The position peaked at $11.5M in Q1 2023. 189 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Gateway Investment Advisers held 7,355 shares of DexCom worth $495K as of Q2 2026.
  • Gateway Investment Advisers sold 415 DexCom shares in Q2 2026, an estimated $27.6K.
  • DexCom made up ﹤0.01% of Gateway Investment Advisers's portfolio in Q2 2026, its #589 holding.
  • Gateway Investment Advisers first reported a position in DexCom in Q4 2018 and has held it in 29 quarters since.
  • Gateway Investment Advisers's DexCom position peaked at $11.5M in Q1 2023.
  • 189 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Gateway Investment Advisers's 13F filing for Q2 2026, filed 20 Jul 2026.